 |
|
|
|
 |
||||||||||||||||||||||||||||||||||||||||
Speedel announced appointment to Management Team18 Sep 2007 - Dr Klaus Dembowsky will Head of Speedel Experimenta, Speedel's late-stage research unit. He is a MD and PhD in physiology and has extensive experience in managing research laboratories in both Big Pharma and Biotech in Germany and the USA with Bayer, Millenium, and Ingenium Pharmaceuticals. Dr Dembowsky will also serve on Speedel's Management Team.Additional information
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
 Top |
|||
Print version
PDF version
Send article
RSS feed